Effect of growth hormone, hyperbaric oxygen and combined therapy on the gastric serosa

Table 2 The per-operative and 3-wk post-operative venous levels of like growth factor and insulin like growth factor binding protein 3 (nmol/L)

	Group 1 (control)	Group 2 (GH therapy)	Group 4 (GH + HBO therapy)	P1(Groups 1-2)	P2(Groups 1-4)
Before the surgery
IGF-1 (nmol/L)	445 (402-482)	421 (405-460)	431 (395-470)	NS	NS
IGFBP-3 (nmol/L)	2250 (2100-2350)	2170 (2000-2300)	2147 (2025-2350)	NS	NS
After the surgery (3 wk)
IGF-1 (nmol/L)	445 (415-500)	799 (755-875)	813 (775-900)	< 0.05	< 0.05
IGFBP-3 (nmol/L)	2290 (2050-2500)	3300 (3000-3600)	3328 (3000-3650)	< 0.05	< 0.05
P	NS	< 0.05	< 0.05

The P value compares the per- and post-operative levels within the same group, P¹ value compares the levels between Groups 1 and 2, and P² value compares the levels between Groups 1 and 4. All values are expressed as the mean ± SD. NS: Non-significant; GH: Growth hormone; HBOT: Hyperbaric oxygen therapy; IGF-1: Like growth factor; IGFBP-3: Insulin like growth factor binding protein 3.